UBIO
Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO
Delisted
UBIO was delisted on the 27th of March, 2020.
8 hedge funds and large institutions have $2.16M invested in Proshares UltraPro NASDAQ Biotechnology in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-1
Holders Change %
-11.11%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
4
Closed
2
Calls
$2K
Puts
$384K
Net Calls
-$382K
Net Calls Change
-$1.06M
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
+$53.9K |
2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$44K |
Top Sellers
1 |
Jane Street
New York
|
-$1.77M |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$790K |
3 |
VF
Virtu Financial
New York
|
-$600K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$64.4K |
5 |
Morgan Stanley
New York
|
-$4.47K |